One third or more of HIV infections in breastfeeding infants are acquired from mother's milk. When economically possible, formula feeding has been suggested as an alternative to breastfeeding for infants born to HIV positive mothers. At the same time, an absence of breastfeeding is likely to increase infant morbidity and mortality, especially in environments where water quality and sewage treatment are not optimal. When zidovudine (ZDV) is given to HIV-infected pregnant mothers for at least four weeks prior to birth it can reduce the rate of in utero and/or perinatal infections by 50 percent or more. Similarly, when nevirapine (NVP) was given to HIV positive mothers during labor and to newborn infants in Uganda it significantly reduced neonatal infections with HIV. We propose a trial with a factorial design to compare breastfeeding with infant ZDV chemoprophylaxis to formula feeding. In the same population we would also compare six weeks of maternal prenatal ZDV plus a dose of maternal NVP during labor and a dose of neonatal NVP within 24 hours after birth. The trial is proposed for Botswana, where the Ministry of Health initiated a feasibility program, beginning in May 1999, to administer six weeks of prenatal ZDV and six months of infant formula feeding to 400 HIV positive women and their infants. In Botswana, the HIV infection rate of pregnant women is estimated to be 38.5 percent. Almost all HIV infections in Botswana are subtype HIV-1C, which has rapidly expanded to account for more than half of the world's HIV infections. Additionally, when compared to other subtypes in Africa, HIV-1C has been found to have elevated rates of mother-to-child transmission (MTCT) and elevated rates of transmission through breast milk.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD037793-03
Application #
6521204
Study Section
Special Emphasis Panel (ZRG1-AARR-6 (01))
Program Officer
Nugent, Robert
Project Start
2000-09-11
Project End
2005-04-30
Budget Start
2002-05-01
Budget End
2003-04-30
Support Year
3
Fiscal Year
2002
Total Cost
$1,626,921
Indirect Cost
Name
Harvard University
Department
Microbiology/Immun/Virology
Type
Schools of Public Health
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02115
Balasubramanian, Raji; Fowler, Mary Glenn; Dominguez, Kenneth et al. (2017) Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1. AIDS 31:2465-2474
Powis, Kathleen M; Smeaton, Laura; Hughes, Michael D et al. (2016) In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana. AIDS 30:211-20
Russell, Elizabeth S; Mohammed, Terence; Smeaton, Laura et al. (2014) Immune activation markers in peripartum women in Botswana: association with feeding strategy and maternal morbidity. PLoS One 9:e89928
Lin, Nina H; Smeaton, Laura M; Giguel, Françoise et al. (2011) Prevalence and clinical associations of CXCR4-using HIV-1 among treatment-naive subtype C-infected women in Botswana. J Acquir Immune Defic Syndr 57:46-50
Dryden-Peterson, Scott; Shapiro, Roger L; Hughes, Michael D et al. (2011) Increased risk of severe infant anemia after exposure to maternal HAART, Botswana. J Acquir Immune Defic Syndr 56:428-36
Powis, Kathleen M; Smeaton, Laura; Ogwu, Anthony et al. (2011) Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana. J Acquir Immune Defic Syndr 56:131-8
Lin, Nina H; Negusse, Daniel M; Beroukhim, Rameen et al. (2010) The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates. J Virol Methods 169:39-46
Novitsky, Vladimir; Wang, Rui; Bussmann, Hermann et al. (2010) HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the ""test-and-treat"" approach to reduce HIV transmission. PLoS One 5:e10148
Rowley, Christopher F; Boutwell, Christian L; Lee, Esther J et al. (2010) Ultrasensitive detection of minor drug-resistant variants for HIV after nevirapine exposure using allele-specific PCR: clinical significance. AIDS Res Hum Retroviruses 26:293-300
Shapiro, Roger L; Smeaton, Laura; Lockman, Shahin et al. (2009) Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana. J Infect Dis 199:414-8

Showing the most recent 10 out of 21 publications